ORIENT BIO Inc. (KRX: 002630)

South Korea flag South Korea · Delayed Price · Currency is KRW
459.00
-1.00 (-0.22%)
Oct 10, 2024, 3:30 PM KST
-26.32%
Market Cap 54.54B
Revenue (ttm) 59.09B
Net Income (ttm) -6.85B
Shares Out 118.57M
EPS (ttm) -57.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 98,127
Open 460.00
Previous Close 460.00
Day's Range 450.00 - 463.00
52-Week Range 444.00 - 688.00
Beta 0.92
Analysts n/a
Price Target n/a
Earnings Date n/a

About ORIENT BIO

ORIENT BIO Inc. operates in the bio-industry in South Korea. It produces laboratory animals; and offers various equipment for research environment. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is based in Seongnam-si, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1959
Employees 125
Stock Exchange Korea Stock Exchange
Ticker Symbol 002630
Full Company Profile

Financial Performance

In 2020, ORIENT BIO's revenue was 52.02 billion, an increase of 39.79% compared to the previous year's 37.21 billion. Losses were -15.63 billion, 30.3% more than in 2019.

Financial Statements

News

There is no news available yet.